7 min read
Milestone Monday
Milestone Monday: The Weekend Madrid Stood Up For Small Cell Lung Cancer
A standing ovation for new small cell lung cancer data led an ESMO weekend in which the winning regimens kept asking less of patients: less chemotherapy, less time in the monitoring chair, fewer people quitting treatment over side effects.